Singapore’s Temasek Holdings has invested USD47.8M in California-based Amyris Biotechnologies. Amyris’ proprietary technology transforms plant-based feedstocks, such as sugarcane into biofuels.
Amyris has previously raised USD244M.
Temasek joins this investor line-up: Kleiner Perkins Caufield & Byers, Khosla Ventures, TPG Biotechnology, Votorantim Novos Negocios, Advanced Equities Inc., DAG Ventures, Grupo Cornélio Brennand, Naxos U.K., The Westly Group, and Stratus Group.
